Search results
Results from the WOW.Com Content Network
Confirmation from a "certifying authority" is required to qualify for service with the NLS. In cases of blindness, visual impairment and/or physical limitations Doctors of Medicine (M.D.); Doctors of Osteopathic Medicine (D.O.); ophthalmologists; optometrists; registered nurses; professional librarians; therapists; and professional staff of hospitals, institutions, and welfare agencies are ...
Velmanase alfa was approved for medical use in the European Union in March 2018, [3] [5] and in the United States in February 2023. [ 2 ] [ 6 ] Velmanase alfa is the first enzyme replacement therapy approved in the US for the treatment of the non-central nervous system manifestations of alpha-mannosidosis. [ 2 ]
The Court held that while Title VII applies a mixed motive discrimination framework to claims of discrimination on the basis of race, color, religion, sex, or national origin (see 42 U.S.C. § 2000e-2), that framework did not apply to claims of retaliation under 42 U.S.C. § 2000e-3. The Court reasoned that based on its decision in Gross v.
MEDLINE (Medical Literature Analysis and Retrieval System Online, or MEDLARS Online) is a bibliographic database of life sciences and biomedical information. It includes bibliographic information for articles from academic journals covering medicine, nursing, pharmacy, dentistry, veterinary medicine, and health care.
With an estimated 52.5 million adults in the U.S. affected by arthritis alone and up to 24% of adults experiencing muscle pain during their lifetime, effective topical pain relievers can be life ...
Clinical duration of action (time from drug administration to recovery of single twich to 25% of baseline) is 7-12 minutes. If IV access is unavailable, intramuscular administration 3-4mg/kg. Paralysis occurs at 4 minutes.
H-Asn 1-Asp 2-Glu 3-Cys 4-Glu 5-Leu 6-Cys 7-Val 8-Asn 9-Val 10-Ala 11-Cys 12-Thr 13-Gly 14-Cys 15-Leu 16-OH (one-letter sequence: NDECELCVNVACTGCL). Plecanatide is nearly structurally identical to human uroguanylin, apart from the substitution of Asp 3 with Glu 3. [13] Disulfide bonds exist between Cys 4 and Cys 12, as well as Cys 7 and Cys 15 ...
Coagulation factor VII (EC 3.4.21.21, formerly known as proconvertin) is a protein involved in coagulation and, in humans, is encoded by gene F7. It is an enzyme of the serine protease class. Once bound to tissue factor released from damaged tissues, it is converted to factor VIIa (or blood-coagulation factor VIIa , activated blood coagulation ...